Envista's global expansion, strategic acquisitions, and solid solvency boost growth outlook despite FX headwinds.
Investors looking for stocks in the Medical - Products sector might want to consider either Envista (NVST) or Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Envista's Q2 results showed broad-based growth, segment recovery, and improved margins, signaling early signs of stabilization and operational turnaround. Spark and implants businesses are rebounding, with Spark on track for profitability and cost efficiencies, and implants seeing sustained growth across regions. One-time revenue tailwinds, FX and tariff risks, and ongoing China uncertainty temper the near-term outlook and earnings growth potential.
Explore how Envista's (NVST) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Envista Holdings Corporation (NYSE:NVST ) Q2 2025 Earnings Conference Call July 31, 2025 5:00 PM ET Company Participants Eric D. Hammes - Senior VP & CFO Jim Gustafson - Vice President of Investor Relations Paul A.
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Envista (NVST) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.11 per share a year ago.
Envista (NVST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Envista Holdings Corporation (NVST) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, NVST's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.